The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.10
Bid: 4.70
Ask: 5.50
Change: 0.00 (0.00%)
Spread: 0.80 (17.021%)
Open: 5.10
High: 5.10
Low: 5.10
Prev. Close: 5.10
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Subscription

15 Sep 2015 09:37

RNS Number : 0705Z
Totally PLC
15 September 2015
 

15 September 2015

 

Totally Plc

("Totally" or the "Company")

 

Completion of Subscription to raise £1.05 million and Share Consolidation

 

Further to the announcement made by the Company on 11 September 2015, the Board of Totally (AIM: TLY), the provider of a range of services to the healthcare sector, is pleased to announce that admission of the New Ordinary Shares (comprising the Subscription Shares and the New Ordinary Shares issued following the consolidation of all the Existing Ordinary Shares) to trading on AIM became effective at 8.00 a.m. this morning, resulting in completion of the Proposals.

Pursuant to the Proposals, the Company has raised £1,050,000 (before expenses) through a subscription for 6,000,000 New Ordinary Shares at 17.5p per New Ordinary Share.

Robert (Bob) Holt has joined Totally's Board as Non-Executive Chairman and Dr Michael Sinclair has stepped down as Non-Executive Chairman and resigned from the Board.

Following approval of Totally's proposed share consolidation at the general meeting of the Company held on 11 September 2015, Shareholders on the register at close of business on 14 September 2015 will receive one consolidated new ordinary share of 10p each, credited as fully paid, in place of every 100 existing ordinary shares of 0.1p each, save for fractional entitlements. The ISIN of the New Ordinary Shares is GB00BYM1JJ00.

The Board confirms that, following Admission of the New Ordinary Shares, the interests of the Directors is as detailed below:

Name of Director

Number of New Ordinary Shares held

Percentage of Total New Ordinary Shares

 

Robert Holt (Chairman)

600,000

6.01%

Don Baladasan (Finance Director)

67,780

0.68%

Andrew Margolis (Chief Operating Officer)

49,082

0.49%

Jack Clipsham (Non-Executive Director)

28,992

0.29%

Wendy Lawrence (Chief Executive Officer)

16,666

0.17%

Dr. Steve Laitner (Non-Executive Director)

-

-

 

Definitions in this announcement are consistent with those set out in the circular issued to Shareholders of the Company on 25 August 2015, a copy of which is available on the investor section of the Company's website (www.totallyplc.com).

For further information please contact:

Totally Plc / Totally Health

Wendy Lawrence, Chief Executive

Bob Holt, Chairman

020 3077 2202

07778 798 816

 

Allenby Capital Limited (Nominated Adviser & Joint Broker)

020 3328 5656

 

Nick Naylor / Nick Athanas / Alex Brearley

 

Optiva Securities Limited (Joint Broker)

020 3137 1902

 

Christian Dennis / Jeremy King

 

Blytheweigh

020 7138 3203

 

Tim Blythe / Wendy Haowei / Andrea Benton

 

 

Notes to Editors

Totally plc is focused on the provision of professional health coaching which promotes and facilitates self care. Totally's services have been shown to reduce costs for Clinical Commissioning Groups by, for example, reducing unplanned admissions to hospitals and visits to Accident and Emergency Departments.

Totally currently operates contracts with NHS England and several CCGs across England delivering their Long Term Condition Management and Shared Decision Making Programs. 

Totally Health is a provider of a range of services to the healthcare sector that supports individuals to better understand their clinical conditions and support them to avoid exacerbations of such conditions and promote self care.

Shared Decision Making and the Management of Long Term Conditions are key strategic areas for the NHS in England. The NHS in England estimates that £7 out of every £10 spent on health and social care is spent looking after people diagnosed with a Long Term Condition.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGMLRKFGKZG
Date   Source Headline
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn
2nd Mar 20239:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Update
28th Feb 20235:00 pmRNSTotal Voting Rights
3rd Feb 20234:41 pmRNSExercise of options, director/PDMR & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.